Literature DB >> 17508923

Protein-protein interaction inhibitors: small molecules from screening techniques.

Steven Fletcher1, Andrew D Hamilton.   

Abstract

Protein-protein interactions play crucial roles in a number of biological processes, and, as such, their disruption is becoming an area of intense research. Despite the many challenges associated with the development of protein-protein interaction inhibitors, such as the large and relatively featureless interfacial areas involved, there has been considerable success in recent years. Importantly, through the existence of protein "hot spots", some of this success takes the form of small molecule inhibitors that have been identified from a variety of screening techniques.

Mesh:

Substances:

Year:  2007        PMID: 17508923     DOI: 10.2174/156802607780906735

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  33 in total

Review 1.  Evolution of immunity: no development without risk.

Authors:  Alexander B Sigalov
Journal:  Immunol Res       Date:  2012-06       Impact factor: 2.829

2.  Leucine-rich repeat-containing protein 59 mediates nuclear import of cancerous inhibitor of PP2A in prostate cancer cells.

Authors:  Rajash Pallai; Aishwarya Bhaskar; Natalie Barnett-Bernodat; Christina Gallo-Ebert; Michelle Pusey; Joseph T Nickels; Lyndi M Rice
Journal:  Tumour Biol       Date:  2015-04-02

3.  Universal peptidomimetics.

Authors:  Eunhwa Ko; Jing Liu; Lisa M Perez; Genliang Lu; Amber Schaefer; Kevin Burgess
Journal:  J Am Chem Soc       Date:  2010-12-23       Impact factor: 15.419

Review 4.  Knitting and untying the protein network: modulation of protein ensembles as a therapeutic strategy.

Authors:  Susana Gordo; Ernest Giralt
Journal:  Protein Sci       Date:  2009-03       Impact factor: 6.725

5.  The SCHOOL of nature: III. From mechanistic understanding to novel therapies.

Authors:  Alexander B Sigalov
Journal:  Self Nonself       Date:  2010-06-11

6.  Protein-protein interactions: making drug design second nature.

Authors:  Dan L Sackett; David Sept
Journal:  Nat Chem       Date:  2009-11       Impact factor: 24.427

7.  Inhibition of protein-protein interactions with low molecular weight compounds.

Authors:  Marilyn M Matthews; David J Weber; Paul S Shapiro; Andrew Coop; Alexander D Mackerell
Journal:  Curr Trends Med Chem       Date:  2008-01-01

8.  Identifying modulators of protein-protein interactions using photonic crystal biosensors.

Authors:  James T Heeres; Seok-Ho Kim; Benjamin J Leslie; Erich A Lidstone; Brian T Cunningham; Paul J Hergenrother
Journal:  J Am Chem Soc       Date:  2009-12-30       Impact factor: 15.419

9.  A quantitative, surface plasmon resonance-based approach to evaluating DNA binding by the c-Myc oncoprotein and its disruption by small molecule inhibitors.

Authors:  Huabo Wang; Anand Ramakrishnan; Steven Fletcher; Edward V Prochownik
Journal:  J Biol Methods       Date:  2015

10.  Assessing the druggability of protein-protein interactions by a supervised machine-learning method.

Authors:  Nobuyoshi Sugaya; Kazuyoshi Ikeda
Journal:  BMC Bioinformatics       Date:  2009-08-25       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.